Behnood Bikdeli1, Brian Wayda1, Haikun Bao1, Joseph S Ross1, Xiao Xu1, Sarwat I Chaudhry1, John A Spertus1, Susannah M Bernheim1, Peter K Lindenauer1, Harlan M Krumholz2. 1. From the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, CT (B.B., B.W., H.B., J.S.R., X.X., S.I.C., S.M.B., H.M.K.); Section of Cardiovascular Medicine, Department of Internal Medicine (B.B., H.M.K.), Section of General Internal Medicine, Department of Internal Medicine (J.S.R., S.I.C., S.M.B.), Department of Obstetrics, Gynecology, and Reproductive Sciences (X.X.), Robert Wood Johnson Clinical Scholars Program, Department of Internal Medicine (H.M.K., J.S.R.), Yale University School of Medicine, New Haven, CT; Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City (J.A.S.); Department of Medicine, Center for Quality of Care Research, Baystate Medical Center, Springfield, MA (P.K.L.); Tufts University School of Medicine, Boston, MA (P.K.L.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K., J.S.R.). 2. From the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, CT (B.B., B.W., H.B., J.S.R., X.X., S.I.C., S.M.B., H.M.K.); Section of Cardiovascular Medicine, Department of Internal Medicine (B.B., H.M.K.), Section of General Internal Medicine, Department of Internal Medicine (J.S.R., S.I.C., S.M.B.), Department of Obstetrics, Gynecology, and Reproductive Sciences (X.X.), Robert Wood Johnson Clinical Scholars Program, Department of Internal Medicine (H.M.K., J.S.R.), Yale University School of Medicine, New Haven, CT; Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City (J.A.S.); Department of Medicine, Center for Quality of Care Research, Baystate Medical Center, Springfield, MA (P.K.L.); Tufts University School of Medicine, Boston, MA (P.K.L.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K., J.S.R.). harlan.krumholz@yale.edu.
Abstract
BACKGROUND: Recent studies show an association between neighborhood-level measures of socioeconomic status (SES) and outcomes for patients with heart failure. We do not know whether neighborhood SES has a primary effect or is a marker for individual SES. METHODS AND RESULTS: We used the data from participants of the Telemonitoring to Improve Heart Failure Outcomes (Tele-HF) trial, recruited from 33 US internal medicine and cardiology practices and examined the association between neighborhood SES and outcomes of patients with heart failure. We used census tracts as proxies for neighborhoods and constructed summary SES scores that included information about wealth and income, education, and occupation. The primary end points were readmission and all-cause mortality at 6 months. We conducted patient interviews and medical chart reviews to obtain demographic information, clinical factors, therapies, and individual SES. We included 1557 patients: 524, 516, and 517 from low, medium, and high SES neighborhoods, respectively (mean age, 61.1±15.2 years; 42.2% women).Overall, 745 patients (47.8%) had ≥1 readmission and 179 patients (11.5%) died. When compared with patients in high SES neighborhoods, those living in low-SES neighborhoods were more likely to be readmitted (odds ratio, 1.35; 95% confidence interval, 1.01-1.82), but the mortality rates were not significantly different (odds ratio, 0.78; 95% confidence interval, 0.50-1.18). The results were consistent after multivariable adjustments for individual demographics, clinical factors, and individual SES. CONCLUSIONS: Among patients with heart failure, neighborhood SES was significantly associated with 6-month all-cause readmission even after adjusting for other patient-level factors, including individual SES. Greater number of events and longer follow-up is required to ascertain the potential effect of neighborhood SES on mortality. CLINICAL TRIAL REGISTRATION URL: http://clinicaltrials.gov/. Unique identifier: NCT00303212.
BACKGROUND: Recent studies show an association between neighborhood-level measures of socioeconomic status (SES) and outcomes for patients with heart failure. We do not know whether neighborhood SES has a primary effect or is a marker for individual SES. METHODS AND RESULTS: We used the data from participants of the Telemonitoring to Improve Heart Failure Outcomes (Tele-HF) trial, recruited from 33 US internal medicine and cardiology practices and examined the association between neighborhood SES and outcomes of patients with heart failure. We used census tracts as proxies for neighborhoods and constructed summary SES scores that included information about wealth and income, education, and occupation. The primary end points were readmission and all-cause mortality at 6 months. We conducted patient interviews and medical chart reviews to obtain demographic information, clinical factors, therapies, and individual SES. We included 1557 patients: 524, 516, and 517 from low, medium, and high SES neighborhoods, respectively (mean age, 61.1±15.2 years; 42.2% women).Overall, 745 patients (47.8%) had ≥1 readmission and 179 patients (11.5%) died. When compared with patients in high SES neighborhoods, those living in low-SES neighborhoods were more likely to be readmitted (odds ratio, 1.35; 95% confidence interval, 1.01-1.82), but the mortality rates were not significantly different (odds ratio, 0.78; 95% confidence interval, 0.50-1.18). The results were consistent after multivariable adjustments for individual demographics, clinical factors, and individual SES. CONCLUSIONS: Among patients with heart failure, neighborhood SES was significantly associated with 6-month all-cause readmission even after adjusting for other patient-level factors, including individual SES. Greater number of events and longer follow-up is required to ascertain the potential effect of neighborhood SES on mortality. CLINICAL TRIAL REGISTRATION URL: http://clinicaltrials.gov/. Unique identifier: NCT00303212.
Authors: Saif S Rathore; Frederick A Masoudi; Yongfei Wang; Jeptha P Curtis; JoAnne M Foody; Edward P Havranek; Harlan M Krumholz Journal: Am Heart J Date: 2006-08 Impact factor: 4.749
Authors: Jens Ludwig; Greg J Duncan; Lisa A Gennetian; Lawrence F Katz; Ronald C Kessler; Jeffrey R Kling; Lisa Sanbonmatsu Journal: Science Date: 2012-09-21 Impact factor: 47.728
Authors: Randi E Foraker; Kathryn M Rose; Chirayath M Suchindran; Patricia P Chang; Ann M McNeill; Wayne D Rosamond Journal: Circ Heart Fail Date: 2011-03-23 Impact factor: 8.790
Authors: Elvis A Akwo; Edmond K Kabagambe; Frank E Harrell; William J Blot; Justin M Bachmann; Thomas J Wang; Deepak K Gupta; Loren Lipworth Journal: Circ Cardiovasc Qual Outcomes Date: 2018-01
Authors: Alon Peltz; Chang L Wu; Marjorie Lee White; Karen M Wilson; Scott A Lorch; Cary Thurm; Matt Hall; Jay G Berry Journal: Pediatrics Date: 2016-04-11 Impact factor: 7.124
Authors: Matthew L Topel; Jeong Hwan Kim; Mahasin S Mujahid; Samaah M Sullivan; Yi-An Ko; Viola Vaccarino; Arshed A Quyyumi; Tené T Lewis Journal: Am J Cardiol Date: 2018-10-22 Impact factor: 2.778
Authors: Sara E Grineski; Danielle X Morales; Timothy Collins; Jacob Wilkes; Joshua L Bonkowsky Journal: J Racial Ethn Health Disparities Date: 2020-02-24